These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study. Baş F, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Sıklar Z, Öcal G, Timirci Ö, Çetinkaya S, Darcan Ş, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R. Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308 [Abstract] [Full Text] [Related]
7. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome]. Li J, Wu W, Liang Y, Luo XP. Zhonghua Er Ke Za Zhi; 2018 Nov 02; 56(11):866-870. PubMed ID: 30392213 [Abstract] [Full Text] [Related]
9. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population. Baş F, Keleşoğlu F, Timirci Ö, Kabataş Eryılmaz S, Bozkurt N, Küçükemre Aydın B, Bundak R, Isbir T, Darendeliler F. J Clin Res Pediatr Endocrinol; 2011 Nov 02; 3(3):126-31. PubMed ID: 21911325 [Abstract] [Full Text] [Related]
16. Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children. Dörr HG, Bettendorf M, Hauffa BP, Mehls O, Rohrer T, Stahnke N, Pfäffle R, Ranke MB, German KIGS Group. Clin Endocrinol (Oxf); 2011 Nov 02; 75(5):656-60. PubMed ID: 21623854 [Abstract] [Full Text] [Related]
18. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. Carrascosa A, Esteban C, Espadero R, Fernández-Cancio M, Andaluz P, Clemente M, Audí L, Wollmann H, Fryklund L, Parodi L, Spanish SGA Study Group. J Clin Endocrinol Metab; 2006 Sep 02; 91(9):3281-6. PubMed ID: 16804042 [Abstract] [Full Text] [Related]
19. d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults. Moyes VJ, Walker DM, Owusu-Antwi S, Maher KT, Metherell L, Akker SA, Monson JP, Clark AJ, Drake WM. Clin Endocrinol (Oxf); 2010 Jun 02; 72(6):807-13. PubMed ID: 20039885 [Abstract] [Full Text] [Related]
20. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. Wassenaar MJ, Dekkers OM, Pereira AM, Wit JM, Smit JW, Biermasz NR, Romijn JA. J Clin Endocrinol Metab; 2009 Oct 02; 94(10):3721-30. PubMed ID: 19584188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]